Publications by authors named "Nathan W Sweeney"

Article Synopsis
  • The study explores how patients with multiple myeloma view and make decisions regarding new therapies, specifically BCMA-targeted treatments, using an 18-question survey conducted via the HealthTree® Cure Hub platform.
  • Out of 325 participants, a significant number expressed interest in trying new therapies; 60% showed likelihood for BCMA CAR T-cell therapy and 74% for bispecific antibodies, although many desired more information about safety and effectiveness.
  • Respondents generally preferred therapies with a lower risk of severe side effects, even if that option required continuous treatment without breaks, indicating a strong focus on managing treatment-related risks.
View Article and Find Full Text PDF

Introduction: Plasma cell disorders (PCD) are a group of conditions characterized by disproportionate proliferation of a single clone of B lymphocytes. Multiple myeloma (MM) is a malignant type of plasma cell disorders. Improvements in MM survival have led patients and physicians to pursue strategies to improve quality of life for those living longer with this disease.

View Article and Find Full Text PDF

Introduction: Integrative Medicine (IM) use and efficacy is poorly defined in those with plasma cell disorders (PCD). A 69-question survey on the subject was hosted on HealthTree.org for 3 months.

View Article and Find Full Text PDF

Purpose: The study of rare diseases, such as multiple myeloma (MM), often experiences unique research hurdles that can delay or prevent lifesaving discoveries. HealthTree Cure Hub is a first-in-class software program designed to overcome these potential research hurdles.

Methods: We assessed whether HealthTree Cure Hub improved four commonly experienced research hurdles such as (1) small numbers of patient accrual to clinical trials and research studies, (2) shallow and isolated data sets, (3) high costs to answer research questions, and (4) lack of long-term follow-up patient data.

View Article and Find Full Text PDF

Psoriasis is a skin condition that affects over 100 million people worldwide, while multiple myeloma (MM) accounts for 10% of all hematologic malignancies in the US. There has been limited research on the intersection of psoriasis and MM, and clinicians often face difficult decisions in treating patients diagnosed with both conditions. For instance, the management of psoriasis with systemic immunotherapies in MM patients can be challenging because of concern about immunosuppression and possible worsening of MM.

View Article and Find Full Text PDF

Purpose: Nonalcoholic fatty liver disease (NAFLD) is considered the most common form of silent liver disease in the United States and obesity is associated with increased risk of NAFLD. Obstructive sleep apnea (OSA) which is common in obese individuals is associated with a greater incidence of NAFLD, which in turn, increases the risk for hepatocellular carcinoma (HCC). It is unclear how obesity, OSA and NAFLD interrelate nor how they collectively contribute to an increased risk for developing HCC.

View Article and Find Full Text PDF